SMAD7 and inflammatory bowel disease: The predominant IBD-associated Smad7 acetylation relies on the enhanced activity of the transcriptional coactivator p300 and reduced expression of SIRT1, a member of the mammalian Sirtuin family, which normally deacetylates the lysine residues of Smad7 (Caruso et al., 2014a).